Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00BTZ
|
||||
Former ID |
DIB010902
|
||||
Drug Name |
CT-003230
|
||||
Synonyms |
CT-0011; CT-003230; CT-007640; CT-007650; CT-007660; CT-007670; CT-007680; CT-008650; CT-0093; CT-0107; CT-0109; Amyloid beta 1-42 inhibitors (Alzheimers/mild cognitive impairment/Downs' syndrome); Amyloid beta 1-42 inhibitors (Alzheimers/mild cognitive impairment/Downs' syndrome), Cognition
|
||||
Indication | Mild cognitive impairment [ICD9: 331.83; ICD10:F06.7] | Investigative | [543619] | ||
Company |
Cognition Therapeutics Inc
|
||||
Target and Pathway | |||||
Target(s) | Amyloid beta A4 protein | Target Info | Inhibitor | [543619] | |
KEGG Pathway | Notch signaling pathway | ||||
Alzheimer's disease | |||||
Reactome | Nuclear signaling by ERBB4 | ||||
Degradation of the extracellular matrix | |||||
Regulated proteolysis of p75NTR | |||||
NRIF signals cell death from the nucleus | |||||
Activated NOTCH1 Transmits Signal to the Nucleus | |||||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |||||
EPH-ephrin mediated repulsion of cells | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.